[1] |
JADOUL M, BIEBER BA, MARTIN P, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients[J]. Kidney Int, 2019, 95( 4): 939- 947. DOI: 10.1016/j.kint.2018.11.038.
|
[2] |
GOODKIN DA, BIEBER B, JADOUL M, et al. Mortality, hospitalization, and quality of life among patients with hepatitis C infection on hemodialysis[J]. Clin J Am Soc Nephrol, 2017, 12( 2): 287- 297. DOI: 10.2215/CJN.07940716.
|
[3] |
Breakthrough One Million/Latest Data on Dialysis Patients in China Released, Heavyweight[EB/OL].( 2023-07-24). https://www.sohu.com/a/705638529_408003. https://www.sohu.com/a/705638529_408003
突破百万/中国透析患者最新数据新鲜出炉, 重磅![EB/OL].( 2023-07-24). https://www.sohu.com/a/705638529_408003. https://www.sohu.com/a/705638529_408003
|
[4] |
GAN LY, WANG DY, BIEBER B, et al. Hepatitis C prevalence, incidence, and treatment in Chinese hemodialysis patients: Results from the dialysis outcomes and practice patterns study-China(2019-21)[J]. Front Med, 2022, 9: 910840. DOI: 10.3389/fmed.2022.910840.
|
[5] |
MARC L, MIHAESCU A, LUPUSORU R, et al. Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy-experience of 10 Romanian HD centers[J]. Int Urol Nephrol, 2023, 55( 11): 2951- 2958. DOI: 10.1007/s11255-023-03587-0.
|
[6] |
MIAO XQ, WANG CR, ZENG C, et al. Prevention and control of hepatitis C virus outbreak event in hemodialysis room[J]. Chin J Infect Contr, 2020, 19( 12): 1140- 1144. DOI: 10.12138/j.issn.1671-9638.20206202.
缪兴全, 王超然, 曾翠, 等. 血液透析室丙型肝炎病毒暴发事件的分析与防控[J]. 中国感染控制杂志, 2020, 19( 12): 1140- 1144. DOI: 10.12138/j.issn.1671-9638.20206202.
|
[7] |
Notice of the National Health Commission on Hepatitis C infection in hemodialysis patients in Dongtai People's Hospital of Jiangsu Province[R/OL]. Network of State Administration and medical administration.( 2019-06-18). http://www.nhc.gov.cn/yzygj/s3594/201906/2d47e45677fe4ff2b12e5afd3eb04891.shtml. http://www.nhc.gov.cn/yzygj/s3594/201906/2d47e45677fe4ff2b12e5afd3eb04891.shtml
国家卫生健康委关于江苏省东台市人民医院发生血液透析患者感染丙肝事件有关情况的通报[R/OL]. 医政医管网.( 2019-06-18). http://www.nhc.gov.cn/yzygj/s3594/201906/2d47e45677fe4ff2b12e5afd3eb04891.shtml. http://www.nhc.gov.cn/yzygj/s3594/201906/2d47e45677fe4ff2b12e5afd3eb04891.shtml
|
[8] |
CAMPO DS, XIA GL, DIMITROVA Z, et al. Accurate genetic detection of hepatitis C virus transmissions in outbreak settings[J]. J Infect Dis, 2016, 213( 6): 957- 965. DOI: 10.1093/infdis/jiv542.
|
[9] |
Centers for Disease Control and Prevention. Health care-Associated Hepatitis B and C Outbreaks(≥2 cases) Reported to the CDC 2008-2019[S/OL]. Atlanta, GA: Centers for Disease Control and Prevention; 2020. https://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm. https://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm
|
[10] |
MOHD HANAFIAH K, GROEGER J, FLAXMAN AD, et al. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence[J]. Hepatology, 2013, 57( 4): 1333- 1342. DOI: 10.1002/hep.26141.
|
[11] |
GIROU E, CHEVALIEZ S, CHALLINE D, et al. Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit[J]. Clin Infect Dis, 2008, 47( 5): 627- 633. DOI: 10.1086/590564.
|
[12] |
CARRILHO FJ, MORAES CR, PINHO JRR, et al. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology[J]. BMC Public Health, 2004, 4: 13. DOI: 10.1186/1471-2458-4-13.
|
[13] |
PETROSILLO N, GILLI P, SERRAINO D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis[J]. Am J Kidney Dis, 2001, 37( 5): 1004- 1010. DOI: 10.1016/s0272-6386(05)80017-4.
|
[14] |
Disease Kidney: Improving Global Outcomes Hepatitis C Work Group. KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease[J]. Kidney Int, 2022, 102( 6S): S129- S205. DOI: 10.1016/j.kint.2022.07.013.
|
[15] |
Standard Operating Procedures for Blood Purification(2021). National Health Commission Office〔2021〕No.552[S/OL].( 2021-11-08). http://www.nhc.gov.cn/yzygj/s7659/202111/6e25b8260b214c55886d6f0512c1e53f.shtml. http://www.nhc.gov.cn/yzygj/s7659/202111/6e25b8260b214c55886d6f0512c1e53f.shtml
血液净化标准操作规程(2021版). 国卫办医函〔2021〕552号[S/OL].( 2021-11-08). http://www.nhc.gov.cn/yzygj/s7659/202111/6e25b8260b214c55886d6f0512c1e53f.shtml. http://www.nhc.gov.cn/yzygj/s7659/202111/6e25b8260b214c55886d6f0512c1e53f.shtml
|
[16] |
FISSELL RB, BRAGG-GRESHAM JL, WOODS JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS[J]. Kidney Int, 2004, 65( 6): 2335- 2342. DOI: 10.1111/j.1523-1755.2004.00649.x.
|
[17] |
SAAB S, MARTIN P, BREZINA M, et al. Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis[J]. Am J Kidney Dis, 2001, 37( 2): 308- 315. DOI: 10.1053/ajkd.2001.21294.
|
[18] |
HUANG CF, DAI CY, WANG CW, et al. Therapy as prevention toward HCV elimination in maintenance hemodialysis: A multi-center, prospective cohort study[J]. Clin Kidney J, 2023, 16( 12): 2429- 2436. DOI: 10.1093/ckj/sfad138.
|
[19] |
LEE JJ, CHANG JM, YANG LJ, et al. Trends of treated hepatitis B, hepatitis C, and tuberculosis infection in long-term hemodialysis patients in Taiwan: A nationwide survey in 2010-2018[J]. J Formos Med Assoc, 2022, 121( Suppl 1): S73- S81. DOI: 10.1016/j.jfma.2021.12.019.
|
[20] |
OKUBO T, ATSUKAWA M, TSUBOTA A, et al. Epidemiological survey of patients with hemodialysis complicated by hepatitis C in Japan[J]. Ther Apher Dial, 2019, 23( 1): 44- 48. DOI: 10.1111/1744-9987.12747.
|